NCT05495750View on ClinicalTrials.gov

Suprazygomatic Maxillary Nerve Block Effect on Systemic Inflammatory Response in Cleft Palate Surgeries

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 24, 2022

Primary Completion Date

January 5, 2024

Study Completion Date

February 25, 2024

Conditions
Perioperative Inflammatory ResponsePostoperative Pain
Interventions
DRUG

Bupivacaine 0.25% Injectable Solution

ultrasound-guided bilateral suprazygomatic maxillary nerve block using 0.15 ml/kg.

Trial Locations (1)

Unknown

Faculty of dentisry Ainshams univeristy, Cairo

All Listed Sponsors
lead

Alaa Mohamed Abdel Salam Ibrahim Soliman

OTHER